10:54 IST
BSE
Other Announcement
Neuland Laboratories Other Announcement
Neuland Laboratories Ltd has filed its quarterly shareholding pattern report as required under SEBI regulations for the period ended June 30, 2026.
Neuland Laboratories Ltd
- Share price
- ₹21,610.00
- Market cap
- ₹27,725 Cr
- Revenue (annual)
- ₹2,023 Cr
- Net profit (annual)
- ₹364.0 Cr
- P/E (TTM)
- 55.7×Sector 47.4×
- Promoter holding
- 32.62%-0.01% QoQ
- FII holding
- 21.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 5Other Announcement 3Financial Results 3Business Update 3Board Meeting Outcome 3Results Update 2Production Started 2Credit Rating 2Capacity Expansion 2Annual General Meeting 2Results Correction 1Management Change 1Dividend 1Debt & Borrowing 1Capital Structure Change 1Board Meeting Date 1Annual Report 1
Time
3 announcements with these filters
20:23 IST
BSE
Other Announcement
Neuland Laboratories Other Announcement
Neuland Laboratories issued a web-link notice for its 42nd AGM and FY 2025-26 Integrated Annual Report. This facilitates access for shareholders with unregistered email addresses.
16:29 IST
BSE
Other Announcement
Neuland Laboratories Other Announcement
Neuland Laboratories Ltd submitted an Annual Compliance Certificate for Davuluri Ownership Trust for FY 2025-26. Issued by M/s. B Srinivasa Rao & Co., the certificate confirms compliance with the SEBI Exemption Order dated January 3, 2025. This is a routine regulatory filing for information and record purposes.